Novel arterial pathology in mice and humans hemizygous for elastin

Dean Y. Li, Gilles Faury, Douglas G. Taylor, Elaine C. Davis, Walter A. Boyle, Robert P. Mecham, Peter Stenzel, Beth Boak, Mark T. Keating

Research output: Contribution to journalArticle

241 Citations (Scopus)

Abstract

Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50% in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2.5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.

Original languageEnglish (US)
Pages (from-to)1783-1787
Number of pages5
JournalJournal of Clinical Investigation
Volume102
Issue number10
StatePublished - Nov 15 1998

Fingerprint

Elastin
Smooth Muscle
Pathology
Vascular Diseases
Supravalvular Aortic Stenosis
Arterial Occlusive Diseases
Compliance
Molecular Biology
Arteries
Alleles
Pressure
Messenger RNA
Mutation
Health
Genes
Proteins

Keywords

  • Cardiovascular models
  • Compliance
  • Elastin
  • Mice, transgenic
  • Vascular disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Li, D. Y., Faury, G., Taylor, D. G., Davis, E. C., Boyle, W. A., Mecham, R. P., ... Keating, M. T. (1998). Novel arterial pathology in mice and humans hemizygous for elastin. Journal of Clinical Investigation, 102(10), 1783-1787.

Novel arterial pathology in mice and humans hemizygous for elastin. / Li, Dean Y.; Faury, Gilles; Taylor, Douglas G.; Davis, Elaine C.; Boyle, Walter A.; Mecham, Robert P.; Stenzel, Peter; Boak, Beth; Keating, Mark T.

In: Journal of Clinical Investigation, Vol. 102, No. 10, 15.11.1998, p. 1783-1787.

Research output: Contribution to journalArticle

Li, DY, Faury, G, Taylor, DG, Davis, EC, Boyle, WA, Mecham, RP, Stenzel, P, Boak, B & Keating, MT 1998, 'Novel arterial pathology in mice and humans hemizygous for elastin', Journal of Clinical Investigation, vol. 102, no. 10, pp. 1783-1787.
Li DY, Faury G, Taylor DG, Davis EC, Boyle WA, Mecham RP et al. Novel arterial pathology in mice and humans hemizygous for elastin. Journal of Clinical Investigation. 1998 Nov 15;102(10):1783-1787.
Li, Dean Y. ; Faury, Gilles ; Taylor, Douglas G. ; Davis, Elaine C. ; Boyle, Walter A. ; Mecham, Robert P. ; Stenzel, Peter ; Boak, Beth ; Keating, Mark T. / Novel arterial pathology in mice and humans hemizygous for elastin. In: Journal of Clinical Investigation. 1998 ; Vol. 102, No. 10. pp. 1783-1787.
@article{73b476a9269749359aa1428f71517f5f,
title = "Novel arterial pathology in mice and humans hemizygous for elastin",
abstract = "Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50{\%} in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35{\%} in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2.5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.",
keywords = "Cardiovascular models, Compliance, Elastin, Mice, transgenic, Vascular disease",
author = "Li, {Dean Y.} and Gilles Faury and Taylor, {Douglas G.} and Davis, {Elaine C.} and Boyle, {Walter A.} and Mecham, {Robert P.} and Peter Stenzel and Beth Boak and Keating, {Mark T.}",
year = "1998",
month = "11",
day = "15",
language = "English (US)",
volume = "102",
pages = "1783--1787",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - Novel arterial pathology in mice and humans hemizygous for elastin

AU - Li, Dean Y.

AU - Faury, Gilles

AU - Taylor, Douglas G.

AU - Davis, Elaine C.

AU - Boyle, Walter A.

AU - Mecham, Robert P.

AU - Stenzel, Peter

AU - Boak, Beth

AU - Keating, Mark T.

PY - 1998/11/15

Y1 - 1998/11/15

N2 - Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50% in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2.5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.

AB - Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene (ELN +/-). Although ELN mRNA and protein were reduced by 50% in ELN +/- mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN +/- arteries. Examination of humans with ELN hemizygosity revealed a 2.5-fold increase in elastic lamellae and smooth muscle. Thus, ELN hemizygosity in mice and humans induces a compensatory increase in the number of rings of elastic lamellae and smooth muscle during arterial development. Humans are exquisitely sensitive to reduced ELN expression, developing profound arterial thickening and markedly increased risk of obstructive vascular disease.

KW - Cardiovascular models

KW - Compliance

KW - Elastin

KW - Mice, transgenic

KW - Vascular disease

UR - http://www.scopus.com/inward/record.url?scp=0032533870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032533870&partnerID=8YFLogxK

M3 - Article

C2 - 9819363

AN - SCOPUS:0032533870

VL - 102

SP - 1783

EP - 1787

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -